Microbe Biosolutions Aps: Financial statements 2023
CVR: 43196782
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Microbe Biosolutions Aps (CVR 43196782) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,158,846 and a net result of DKK 73,339. Equity in the 2023 report amounted to DKK 426,607. The solvency ratio was 16.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,158,846
- Profit/Loss
- DKK 73,339
- Equity
- DKK 426,607
- Total Assets
- DKK 2,607,533
- Employees
- 2
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 1, 2023, A/S PSE 17 NR. 1056 has been appointed auditor of Microbe Biosolutions Aps.
As of December 1, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Microbe Biosolutions Aps.
Microbe Biosolutions Aps has published its interim report for the period April 13, 2022 – December 31, 2022.
About Microbe Biosolutions Aps
Microbe Biosolutions Aps is a Danish company of the type Anpartsselskab based in Ribe, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Hybridfilter ApS and KWS 2 Tradsborg ApS. The management consists of Michael Bayer Thomsen. The company is owned by KWS HOLDING, TJÆREBORG ApS and MUTAG A/S. According to the 2025 annual report, the company had an average of 3 employees. In 2025, the company reported a gross profit of DKK -749,838 and a net result of DKK -2,235,594 compared with DKK 20,122 the year before. Equity in the 2025 report amounted to DKK -1,788,865.